EMERGENT BIOSOLUTIONS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.93 USD | +2.66% |
|
-11.47% | -19.58% |
| 07:15am | News Highlights : Top Company News of the Day - Thursday at 1 AM ET | DJ |
| 05:15am | News Highlights : Top Company News of the Day - Wednesday at 11 PM ET | DJ |
Chart calendar Emergent BioSolutions Inc.
5d9521e683885ae4ecfa6774c4f.2utK97gGhMwjkc5CMynfbjWDH852Do4Die3dkSJ9Ms0.irgJvflEvZNF8K8ufhmmGAzba5kcfexFsKyF13dEVbSQgSKf7GP8tA7E-g~9509e208975a22bc9636fee44bc40963
Upcoming events on Emergent BioSolutions Inc.
Past events on Emergent BioSolutions Inc.
| 01/05/2024 22:00 | Q1 2024 Earnings Call |
| 30/04/2024 | Q1 2024 Earnings Release After hours |
| 06/03/2024 22:00 | Q4 2023 Earnings Call |
| 06/03/2024 21:31 | Q4 2023 Earnings Release |
| 11/01/2024 17:00 | JPMorgan Healthcare Conference |
| 07/12/2023 19:15 | Singular Research Best of the Uncovered Conference |
| 08/11/2023 22:38 | Q3 2023 Earnings Release |
| 08/11/2023 22:00 | Q3 2023 Earnings Call |
| 13/09/2023 22:30 | Singular Research Autumn Equinox Conferece |
| 08/08/2023 22:00 | Q2 2023 Earnings Call |
| 08/08/2023 21:31 | Q2 2023 Earnings Release |
| 25/05/2023 14:00 | Annual General Meeting |
| 09/05/2023 22:00 | Q1 2023 Earnings Call |
| 09/05/2023 21:05 | Q1 2023 Earnings Release |
| 27/02/2023 22:00 | Q4 2022 Earnings Call |
| 27/02/2023 21:42 | Q4 2022 Earnings Release |
| 15/11/2022 | Three Part Advisors 2022 Southwest IDEAS Conference |
| 08/11/2022 22:00 | Q3 2022 Earnings Call |
| 07/11/2022 | Q3 2022 Earnings Release After hours |
| 14/09/2022 15:45 | Singular Research Autumn Equinox Compelling Values Conference |
Past dividends on Emergent BioSolutions Inc.
| 31/07/2016 | 0 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 106 1 104 0.18% | 1 555 1 547 0.52% | 1 793 1 746 2.65% | 1 121 1 088 2.98% | 1 049 1 047 0.19% | 1 015 |
|
EBITDA Million USD | Released Forecast Spread | 280 265 5.36% | 630 630 0.07% | 518 498 3.94% | 26,1 10,0 161% | -22,3 -0,10 -22200% | 75,0 |
|
EBIT Million USD | Released Forecast Spread | 114 124 -7.99% | 434 401 8.15% | 353 362 -2.69% | -173 -164 -5.25% | -726 -435 -66.88% | -88,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 77,4 86,2 -10.26% | 407 370 9.92% | 314 326 -3.43% | -222 -216 -2.46% | -731 -708 -3.25% | -160 |
|
Net income Million USD | Released Forecast Spread | 54,5 56,4 -3.33% | 305 300 1.65% | 231 267 -13.68% | -224 -203 -10.08% | -761 -742 -2.47% | -155 |
|
EPS USD | Released Forecast Spread | 1,04 1,07 -2.88% | 5,67 5,52 2.72% | 4,27 5,07 -15.72% | -4,47 -4,16 -7.55% | -14,9 -14,4 -3.45% | -2,99 |
| Announcement Date | 20/02/20 | 18/02/21 | 24/02/22 | 27/02/23 | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 723 677 6.84% | 308 285 7.98% | 243 268 -9.56% | 240 266 -9.89% | 331 298 10.89% | 165 143 15.58% | 338 217 55.89% | 271 238 13.87% | 277 274 0.95% | 225 | 245 | 268 | 288 |
|
EBITDA Million USD | Released Forecast Spread | 348 328 5.97% | 36,0 28,3 27.43% | -28,8 45,8 -162.95% | -15,2 | 34,2 18,0 90% | -101 18,0 -660% | 55,9 6,60 746.97% | 19,8 24,6 -19.51% | 3,40 25,0 -86.4% | -5,50 | 9,50 | 28,0 | 43,0 |
|
EBIT Million USD | Released Forecast Spread | 277 315 -11.87% | 6,40 11,5 -44.35% | -72,0 26,2 -374.81% | -42,0 -3,75 -1020% | -65,1 -56,5 -15.29% | -148 -80,6 -83.75% | 13,8 -45,5 130.33% | -242 -25,9 -834.75% | -43,8 -14,5 -202.07% | -40,5 | -30,5 | -17,0 | -7,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 268 307 -12.94% | -3,80 2,25 -268.89% | -82,8 17,4 -575.86% | -63,9 -12,7 -405.14% | -71,2 -66,0 -7.88% | -161 -89,5 -80% | -250 -60,6 -312.87% | -266 -32,6 -715.64% | -54,5 -31,0 -75.81% | -58,0 | -48,0 | -34,5 | -24,5 |
|
Net income Million USD | Released Forecast Spread | 189 222 -14.58% | -3,70 -5,45 32.11% | -56,4 26,5 -313.23% | -75,7 -4,00 -1792.5% | -88,0 -79,3 -10.97% | -183 -67,0 -173.34% | -261 -54,3 -381.22% | -263 -29,8 -785.38% | -49,5 -35,0 -41.43% | -55,5 | -45,5 | -32,0 | -22,0 |
|
EPS USD | Released Forecast Spread | 3,50 4,28 -18.2% | -0,07 -0,15 51.94% | -1,13 -0,40 -184.87% | -1,52 -0,33 -355.36% | -1,76 -1,42 -24.18% | -3,65 -1,63 -123.36% | -5,15 -0,99 -420.2% | -5,08 -0,54 -840.74% | -0,95 -0,60 -58.51% | -1,11 | -1,05 | -0,27 | -0,56 |
| Announcement Date | 24/02/22 | 28/04/22 | 01/08/22 | 08/11/22 | 27/02/23 | 09/05/23 | 08/08/23 | 08/11/23 | 06/03/24 | - | - | - | - |
More events
Past sector events for Emergent BioSolutions Inc.
| Today 06:30 | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| Today | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| Today | AMGEN INC.: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 01/05/2024 11:45 | PFIZER, INC.: Q1 2024 Earnings Release |
| 01/05/2024 08:00 | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 01/05/2024 07:00 | GSK PLC: Q1 2024 Earnings Release |
| 30/04/2024 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EBS Stock
- Calendar Emergent BioSolutions Inc.
